• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share
August 3, 2017
Contact: HHS Press Office
[email protected]

HHS Secretary Statement on FDA Reauthorization Act of 2017

Health and Human Services Secretary Tom Price, M.D. issued the following statement on the FDA Reauthorization Act of 2017:

“Congress is to be commended for passing the FDA Reauthorization Act of 2017. This bill is a vital first step to accomplishing our goal of expanding access to affordable, life-saving drugs and medical devices in a thoughtful manner that protects taxpayer resources, promotes competition, improves healthcare outcomes, and stimulates scientific innovation and medical advances. We welcome this progress.  To accomplish this goal more fully for the American people, more work remains to be done. Together with FDA Commissioner, Dr. Scott Gottlieb, we will continue to work with Congress to ensure that FDA remains the gold standard in advancing medical breakthroughs that will improve the health and well-being of the American people.”

Note: All HHS press releases, fact sheets and other news materials are available at https://www.hhs.gov/news.
Like HHS on Facebook, follow HHS on Twitter @HHSgov, and sign up for HHS Email Updates.
Last revised: August 3, 2017

Subscribe to RSS

Receive latest updates

Subscribe to our RSS